Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Stock-based Compensation and Other Benefit Plans - Weighted Average Assumptions (Details)

v3.23.1
Note 15 - Stock-based Compensation and Other Benefit Plans - Weighted Average Assumptions (Details)
2 Months Ended
Mar. 31, 2022
$ / shares
Weighted average exercise price - ($/share) (in dollars per share) $ 6.41
Expected life in years (Year) 6 years
Average expected volatility 72.00%
Risk-free interest rate 1.98%
Expected dividend yield 2.30%
Weighted average grant date fair value - ($/share) (in dollars per share) $ 2.84